Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 151 entries
View as:

Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT01321567 Org: User:
Start: 01/01/11 End: 08/01/13 Due: 08/01/14

A Pharmacokinetic (PK) Study of Three Types of E0302 Sustained Release (SR) Tablets Compared With E0302 Immediate Release (IR) Tablet Under Fed Conditions in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03885882 Org: User:
Start: 04/13/19 End: 06/26/19 Due: 06/26/20

A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders

Phase: N/A Priority: Normal
NCT ID: NCT05633108 Org: User:
Start: 03/30/23 End: 09/30/23 Due: 09/30/24

A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT02135107 Org: User:
Start: 09/30/13 End: 06/30/16 Due: 06/30/17

Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women

Phase: N/A Priority: Normal
NCT ID: NCT00165698 Org: User:
Start: 05/31/05 End: 07/31/07 Due: 07/31/08

A Study to Assess Safety, Tolerability, and Pharmacokinetics of E2307 in Healthy Young and Elderly Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02289599 Org: User:
Start: 11/30/14 End: 07/31/15 Due: 07/31/16

Clinical Trial of Ultra-high Dose Methylcobalamin for ALS

Phase: N/A Priority: Normal
NCT ID: NCT03548311 Org: User:
Start: 11/01/17 End: 02/18/25 Due: 02/18/26

A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)

Phase: N/A Priority: Normal
NCT ID: NCT00543855 Org: User:
Start: 11/30/07 End: 02/28/10 Due: 02/28/11

A Study to Assess the Effect of Food Intake and Drug-drug Interactions of E7090 When Co-administered With Rabeprazole or Rifampin in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04565574 Org: User:
Start: 10/16/20 End: 03/31/21 Due: 03/31/22

A Study of Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03418922 Org: User:
Start: 01/16/18 End: 12/28/22 Due: 12/28/23

Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01539031 Org: User:
Start: 03/31/12 End: 03/31/15 Due: 03/31/16

A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)

Phase: N/A Priority: Normal
NCT ID: NCT01055834 Org: User:
Start: 01/31/10 End: 02/28/10 Due: 02/28/11

Pharmacokinetic Study of E7080/Lenvatinib in Chinese Subjects With Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT03009292 Org: User:
Start: 08/06/18 End: 08/27/21 Due: 08/27/22

A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)

Phase: N/A Priority: Normal
NCT ID: NCT02345213 Org: User:
Start: 03/01/15 End: 03/26/18 Due: 03/26/19

A Clinical Trial to Study the Effects of a Fixed Dose Combination of Diclofenac and Eperisone Hydrochloride With Plain Eperisone Hydrochloride in Patients With Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT01300312 Org: User:
Start: 02/28/11 End: 09/30/11 Due: 09/30/12

Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02162251 Org: User:
Start: 06/01/13 End: 04/15/16 Due: 04/15/17

Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A

Phase: N/A Priority: Normal
NCT ID: NCT02175719 Org: User:
Start: 04/16/13 End: 12/31/17 Due: 12/31/18

A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China

Phase: N/A Priority: Normal
NCT ID: NCT02966093 Org: User:
Start: 01/11/17 End: 12/29/21 Due: 12/29/22

A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT00965757 Org: User:
Start: 07/31/09 End: 09/30/11 Due: 09/30/12

A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00619164 Org: User:
Start: 11/30/07 End: - Due: -

Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma With EZH2 Gene Mutation

Phase: N/A Priority: Normal
NCT ID: NCT03456726 Org: User:
Start: 04/09/18 End: 12/17/21 Due: 12/17/22

A Phase I Study of E7050 in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01428141 Org: User:
Start: 09/30/11 End: 07/31/13 Due: 07/31/14

A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab

Phase: N/A Priority: Normal
NCT ID: NCT06322667 Org: User:
Start: 02/14/24 End: 12/31/27 Due: 12/31/28

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

Phase: N/A Priority: Normal
NCT ID: NCT03059329 Org: User:
Start: 08/01/16 End: 09/13/19 Due: 09/13/20

A Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03009344 Org: User:
Start: 01/10/17 End: 06/17/20 Due: 06/17/21